Yoav Lurie

6.0k total citations
84 papers, 2.4k citations indexed

About

Yoav Lurie is a scholar working on Hepatology, Epidemiology and Surgery. According to data from OpenAlex, Yoav Lurie has authored 84 papers receiving a total of 2.4k indexed citations (citations by other indexed papers that have themselves been cited), including 54 papers in Hepatology, 46 papers in Epidemiology and 9 papers in Surgery. Recurrent topics in Yoav Lurie's work include Hepatitis C virus research (47 papers), Liver Disease Diagnosis and Treatment (35 papers) and Hepatitis B Virus Studies (30 papers). Yoav Lurie is often cited by papers focused on Hepatitis C virus research (47 papers), Liver Disease Diagnosis and Treatment (35 papers) and Hepatitis B Virus Studies (30 papers). Yoav Lurie collaborates with scholars based in Israel, United States and Germany. Yoav Lurie's co-authors include Avraham Ishay, Deeb Daoud Naccache, Elon Eisenberg, Rafael Esteban, Marı́a Buti, Laurence M. Blendis, Zamir Halpern, Moshe Leshno, Ran Oren and M Espirito Santo and has published in prestigious journals such as The Lancet, Nature Communications and Gastroenterology.

In The Last Decade

Yoav Lurie

82 papers receiving 2.3k citations

Peers

Yoav Lurie
V. Loustaud‐Ratti France
Philippe Sogni France
Yueyong Zhu China
Conrado Fernández‐Rodríguez Spain
Melanie Deutsch Greece
David van der Poorten Australia
Kristian Bjøro Norway
Gian Paolo Caviglia Italy
Thomas Kiernan United States
Daiki Habu Japan
V. Loustaud‐Ratti France
Yoav Lurie
Citations per year, relative to Yoav Lurie Yoav Lurie (= 1×) peers V. Loustaud‐Ratti

Countries citing papers authored by Yoav Lurie

Since Specialization
Citations

This map shows the geographic impact of Yoav Lurie's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yoav Lurie with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yoav Lurie more than expected).

Fields of papers citing papers by Yoav Lurie

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yoav Lurie. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yoav Lurie. The network helps show where Yoav Lurie may publish in the future.

Co-authorship network of co-authors of Yoav Lurie

This figure shows the co-authorship network connecting the top 25 collaborators of Yoav Lurie. A scholar is included among the top collaborators of Yoav Lurie based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yoav Lurie. Yoav Lurie is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Patalon, Tal, Yaki Saciuk, Asaf Peretz, et al.. (2022). Waning effectiveness of the third dose of the BNT162b2 mRNA COVID-19 vaccine. Nature Communications. 13(1). 3203–3203. 91 indexed citations
2.
Lurie, Yoav, et al.. (2016). “No Good Deed Goes Unpunished”: Ignaz Semmelweis and the Story of Puerperal Fever. Infection Control and Hospital Epidemiology. 37(8). 881–887. 8 indexed citations
3.
Lurie, Yoav. (2015). Non-invasive diagnosis of liver fibrosis and cirrhosis. World Journal of Gastroenterology. 21(41). 11567–11567. 268 indexed citations
4.
Kondratyev, Maria, et al.. (2011). A Secreted Form of the Asialoglycoprotein Receptor, sH2a, as a Novel Potential Noninvasive Marker for Liver Fibrosis. PLoS ONE. 6(11). e27210–e27210. 6 indexed citations
5.
Schiff, Eugene R., Samuel S. Lee, You‐Chen Chao, et al.. (2010). Long-Term Treatment With Entecavir Induces Reversal of Advanced Fibrosis or Cirrhosis in Patients With Chronic Hepatitis B. Clinical Gastroenterology and Hepatology. 9(3). 274–276.e1. 137 indexed citations
6.
Maor‬‏, ‪Yasmin, Jonathan Schapiro, Dalia Bashari, et al.. (2008). Treatment of hepatitis C in patients with haemophilia – the Israeli National Hemophilia Center experience. Haemophilia. 14(2). 336–342. 7 indexed citations
7.
Şentürk, Hakan, Yoav Lurie, Adrián Gadano, et al.. (2007). [517] ETV RE-TREATMENT OF NUCLEOSIDE-NAIVE HBeAg(−) PATIENTS. Journal of Hepatology. 46. S197–S197. 4 indexed citations
8.
9.
Pilli, Massimo, Alessandro Zerbini, Amalia Penna, et al.. (2007). HCV-Specific T-Cell Response in Relation to Viral Kinetics and Treatment Outcome (DITTO-HCV Project). Gastroenterology. 133(4). 1132–1143. 51 indexed citations
10.
Lurie, Yoav, Dan‐Avi Landau, Laurence M. Blendis, et al.. (2006). Acute hepatitis C in Israel: A predominantly iatrogenic disease?. Journal of Gastroenterology and Hepatology. 22(2). 158–164. 5 indexed citations
11.
Fishman, Sigal, Yoav Lurie, Hava Peretz, et al.. (2006). Role of CYP2D6 polymorphism in predicting liver fibrosis progression rate in Caucasian patients with chronic hepatitis C. Liver International. 26(3). 279–284. 6 indexed citations
12.
González‐Peralta, Regino P., Déirdre Kelly, Barbara Haber, et al.. (2005). Interferon Alfa-2b in Combination With Ribavirin for the Treatment of Chronic Hepatitis C in Children: Efficacy, Safety, and Pharmacokinetics *. Hepatology. 42(5). 1010–1018. 85 indexed citations
13.
Zeuzem, Stefan, Jean–Michel Pawlotsky, Michael Wagner, et al.. (2005). International, multicenter, randomized, controlled study comparing dynamically individualized versus standard treatment in patients with chronic hepatitis C. Journal of Hepatology. 43(2). 250–257. 113 indexed citations
14.
Schmilovitz‐Weiss, Hemda, Ziv Ben‐Ari, Emanuel Sikuler, et al.. (2004). Lamivudine treatment for acute severe hepatitis B: a pilot study. Liver International. 24(6). 547–551. 57 indexed citations
15.
Lurie, Yoav, Frederik Nevens, Yaron Ilan, et al.. (2002). A multicentre, randomized study to evaluate the safety and efficacy of histamine dihydrochloride and interferon‐α‐2b for the treatment of chronic hepatitis C. Journal of Viral Hepatitis. 9(5). 346–353. 23 indexed citations
16.
Malnick, Stephen, et al.. (1998). Celiac Sprue Presenting During the Puerperium. Journal of Clinical Gastroenterology. 26(3). 164–166. 20 indexed citations
17.
Rimon, Eli, et al.. (1998). Acute hepatitis C during pregnancy. Archives of Gynecology and Obstetrics. 262(1-2). 95–97. 5 indexed citations
18.
Rubinstein, Ardon, et al.. (1991). Cholesterol-lowering effects of a 10 mg daily dose of lovastatin in patients with initial total cholesterol levels 200 to 240 mg/dl (5.18 to 6.21 mmol/liter). The American Journal of Cardiology. 68(11). 1123–1126. 16 indexed citations
19.
Beigel, Yitzhak, et al.. (1991). Lovastatin therapy in heterozygous familial hypercholesterolaemic patients: effect on blood rheology and fibrinogen levels. Journal of Internal Medicine. 230(1). 23–27. 21 indexed citations
20.
Fuchs, J, N. Schoenfeld, Leonard Leibovici, et al.. (1990). Effects of fish-oil ingestion on cardiovascular risk factors in hyperlipidemic subjects in Israel: a randomized, double-blind crossover study. American Journal of Clinical Nutrition. 52(6). 1118–1124. 25 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by V. Loustaud‐Ratti Breakdown of academic impact, for papers by Philippe Sogni Breakdown of academic impact, for papers by Yueyong Zhu Breakdown of academic impact, for papers by Conrado Fernández‐Rodríguez Breakdown of academic impact, for papers by Melanie Deutsch Breakdown of academic impact, for papers by David van der Poorten Breakdown of academic impact, for papers by Kristian Bjøro Breakdown of academic impact, for papers by Gian Paolo Caviglia Breakdown of academic impact, for papers by Thomas Kiernan Breakdown of academic impact, for papers by Daiki Habu
Rankless by CCL
2026